Krystyna Ossowska

Years Active: 2015-2021
Publications (10 Years): 5

Institute of Pharmacology, Polish Academy of Sciences

Institute of Pharmacology, Polish Academy of Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Pharmacology, Polish Academy of Sciences Feb 01 1977

Poland

Professor :: Neuro-Psychopharmacology

Education History

Institute of Pharmacology, Polish Academy of Sciences

Poland

PHD

Jagiellonian University Oct 01 1971 - Jun 30 1976

Poland

MSC :: Biology and Earth Sciences

Publications

Katarzyna Z Kuter, Maria Śmiałowska, Krystyna Ossowska
The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system. Pharmacological reports : PR (2021)
Barbara Kosmowska, Krystyna Ossowska, Jadwiga Wardas
Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor. Neurochemical research 45 (7) (2020)
Krystyna Ossowska, Barbara Kosmowska, Jadwiga Wardas
Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models. Pharmacological reports : PR 72 (3) (2020)
Krystyna Ossowska
Zona incerta as a therapeutic target in Parkinson's disease. Journal of neurology 267 (3) (2019)
Barbara Kosmowska, Krystyna Ossowska, Urszula Głowacka, Jadwiga Wardas
Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats. CNS neuroscience & therapeutics 23 (5) (2017)
Barbara Kosmowska, Jadwiga Wardas, Urszula Głowacka, Subramaniam Ananthan, Krystyna Ossowska
Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats. CNS neuroscience & therapeutics 22 (1) (2015)

Krystyna Ossowska.css-eqlu8i{font-size:small;padding-left:4px;}